^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
talacotuzumab (JNJ-56022473)
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
CSL Behring, J&J
Drug class:
CD123 inhibitor
Related drugs:
